InnovAge
INNV
$4.66
Share price
-8.81%
Change (1 day)
-34.27%
Change (1 year)
Categories
InnovAge (INNV) - Total debt
Total debt on the balance sheet as of March 2024 : $0.11 B
According to InnovAge's latest financial reports the company's total debt is $0.11 B. A company’s total debt is the sum of all current and non-current debts.
InnovAge - Total debt on balance sheet (from 2020 to 2024)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-06-30 | $0.10 B | 28.32% |
| 2022-06-30 | $84.81 M | 2.64% |
| 2021-06-30 | $82.63 M | -62.09% |
| 2020-06-30 | $0.21 B | 11.9% |
| 2019-06-30 | $0.19 B |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Merck MRK | $34.21 B | 30,471.79% | 🇺🇸 USA |
 Cocrystal Pharma
COCP | $1.82 M | -98.37% | 🇺🇸 USA |
 AcelRx Pharmaceuticals
ACRX | $3.36 M | -96.99% | 🇺🇸 USA |
 Horizon Therapeutics
HZNP | $2.55 B | 2,184.87% | 🇮🇪 Ireland |